-transparent.png){kind=logo}
This study was designed to compare the therapeutic and adverse effects of tranylcypromine (a monoamine oxidase inhibitor), nortriptyline (a tricyclic antidepressant), and placebo. A total of 122 depressed outpatients randomly assigned to double-blind treatment with one of these agents completed the 4-week protocol. Treatment groups were balanced for proportions of endogenous versus nonendogenous depressions, defined according to the Research Diagnostic Criteria; however, nonendogenous depressions outnumbered endogenous depressions by such a large proportion (4:1) that meaningful statistical comparisons were limited to the nonendogenous group. In this group, both active drugs proved more effective than placebo, with little differences between the two active drugs except in the areas of side effects and of differential sensitivity of the outcome scales to a given drug. It was concluded that tranylcypromine, a drug which has received relatively little use and study in recent years, represents an effective and reasonably safe treatment for nonendogenous depression, although significant advantages over tricyclics with this disorder remain to be demonstrated.
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
June 1969,
Canadian Psychiatric Association journal,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
January 1989,
Acta psychiatrica Scandinavica. Supplementum,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
January 1985,
Neuropsychobiology,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
March 1998,
The American journal of psychiatry,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
July 1972,
The Journal of clinical pharmacology and new drugs,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
January 1995,
Journal of affective disorders,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
September 1975,
The Medical journal of Australia,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
August 1982,
Acta psychiatrica Scandinavica,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
February 1992,
The Journal of clinical psychiatry,
K White, and
J Razani, and
B Cadow, and
R Gelfand, and
R Palmer, and
G Simpson, and
R B Sloane
April 1984,
The Journal of clinical psychiatry,
